Intended for healthcare professionals

Analysis

Diagnostic expansion in clinical trials: myocardial infarction, stroke, cancer recurrence, and metastases may not be the hard endpoints you thought they were

BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k3783 (Published 19 September 2018) Cite this as: BMJ 2018;362:k3783